RSS
10 Sep 2023

Dizal Announces Clinical Results of Golidocitinib Published in Annals of Oncology

Author: admintech | Filed under: Press Release

SHANGHAI, Sept. 10, 2023 /PRNewswire/ — Dizal today announced the publication of the Phase I clinical data of golidocitinib for the treatment of relapsed or refractory (r/r) peripheral T cell lymphomas (PTCL) (JACKPOT8 PARTA) in Annals of Oncology (2022-2023 Impact Factor: 51.8). PTCL is…

This entry was posted on Sunday, September 10th, 2023 at 7:11 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»